These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
3. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175 [TBL] [Abstract][Full Text] [Related]
4. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas. Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548 [TBL] [Abstract][Full Text] [Related]
5. [Aberrant methylation of NF2, TIMP-3 and THBS1 genes and their diagnostic values in meningiomas]. Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2889-92. PubMed ID: 23328233 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index. Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314 [TBL] [Abstract][Full Text] [Related]
7. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas. Vasan V; Dullea JT; Devarajan A; Ali M; Rutland JW; Gill CM; Kinoshita Y; McBride RB; Gliedman P; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK J Neurooncol; 2023 Jan; 161(2):309-316. PubMed ID: 36436149 [TBL] [Abstract][Full Text] [Related]
10. NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study. Buccoliero AM; Castiglione F; R Degl'Innocenti D; Gheri CF; Garbini F; Taddei A; Ammannati F; Mennonna P; Taddei GL Neuropathology; 2007 Feb; 27(1):36-42. PubMed ID: 17319281 [TBL] [Abstract][Full Text] [Related]
11. NF2 mutations in secretory and other rare variants of meningiomas. Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978 [TBL] [Abstract][Full Text] [Related]
12. Whole exome sequencing of multiple meningiomas with varying histopathological presentation in one patient revealed distinctive somatic mutation burden and independent clonal origins. Sheng HS; Shen F; Zhang N; Yu LS; Lu XQ; Zhang Z; Fang HY; Zhou LL; Lin J Cancer Manag Res; 2019; 11():4085-4095. PubMed ID: 31123420 [No Abstract] [Full Text] [Related]
13. Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas. Shen Y; Nunes F; Stemmer-Rachamimov A; James M; Mohapatra G; Plotkin S; Betensky RA; Engler DA; Roy J; Ramesh V; Gusella JF BMC Med Genomics; 2009 Jul; 2():42. PubMed ID: 19589153 [TBL] [Abstract][Full Text] [Related]
14. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329 [TBL] [Abstract][Full Text] [Related]
16. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854 [TBL] [Abstract][Full Text] [Related]
17. Evidence for subarachnoid spread in the development of multiple meningiomas. von Deimling A; Kraus JA; Stangl AP; Wellenreuther R; Lenartz D; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD Brain Pathol; 1995 Jan; 5(1):11-4. PubMed ID: 7767486 [TBL] [Abstract][Full Text] [Related]
18. Pathology and genetics of meningiomas. Alahmadi H; Croul SE Semin Diagn Pathol; 2011 Nov; 28(4):314-24. PubMed ID: 22195409 [TBL] [Abstract][Full Text] [Related]
19. A role for the p53 pathway in the pathology of meningiomas with NF2 loss. Chang Z; Guo CL; Ahronowitz I; Stemmer-Rachamimov AO; MacCollin M; Nunes FP J Neurooncol; 2009 Feb; 91(3):265-70. PubMed ID: 18974932 [TBL] [Abstract][Full Text] [Related]